Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19.
J Virus Erad
; 6(2): 52-60, 2020 Apr 30.
Article
en En
| MEDLINE
| ID: mdl-32405422
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Health_economic_evaluation
/
Systematic_reviews
Idioma:
En
Año:
2020
Tipo del documento:
Article